Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: all 582 studies

Page 4 of 6. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.

• Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00052715Phase 2Results posted
• Benzoylphenylurea in Treating Patients With Advanced Solid TumorsCompletedNCT00016354Phase 1Results posted
• Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive InterventionsActive, not recruitingNCT06463249Not applicable
• PSMA Therapy and Immunotherapy in Kidney CancerWithdrawnNCT06361810Phase 1/2
• 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic CarcinomaTerminatedNCT06322576Phase 2
• Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT06122480Not applicable
• DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)Active, not recruitingNCT06027086Phase 1/2
• Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate CancerActive, not recruitingNCT06014255Phase 2
• Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).Active, not recruitingNCT05977907Phase 2
• Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older PatientsActive, not recruitingNCT05823571Phase 1
• Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AMLTerminatedNCT05716009Phase 1
• A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate CancerWithdrawnNCT05574712Phase 2
• SMART-ER: Symptom Monitoring With Patient-reported OutcomesTerminatedNCT05560685Not applicable
• Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without NivolumabWithdrawnNCT05472623Phase 2
• Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPSWithdrawnNCT05302570Phase 2
• RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic SclerosisTerminatedNCT05298358Phase 1
• Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic AdenocarcinomaActive, not recruitingNCT05141513Phase 1
• TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated CancersWithdrawnNCT05132803Phase 1
• Proton Pencil Beam Scanning GRID for Treatment of Bulky TumorsActive, not recruitingNCT05121545Not applicable
• Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell CarcinomaTerminatedNCT05103722Not applicable
• Skeletal Metastasis RegistryTerminatedNCT05058014
• Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic CancerActive, not recruitingNCT05013216Phase 1
• HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk FactorsCompletedNCT04979000
• 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)WithdrawnNCT04926168
• Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to ApixabanTerminatedNCT04895553
• Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck CaActive, not recruitingNCT04848116Phase 2
• Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) PatientsTerminatedNCT04843306Not applicable
• Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWithdrawnNCT04799431Phase 1
• Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Active, not recruitingNCT04753879Phase 2
• Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ CancersActive, not recruitingNCT04713046Phase 1/2
• Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04658147Phase 1
• Behavioral Weight Loss Program for Cancer Survivors in MarylandCompletedNCT04534309Not applicable
• Brachytherapy Innovations in Gynecologic CancerWithdrawnNCT04530019
• [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate CancerTerminatedNCT04528199Phase 1
• PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)TerminatedNCT04524195Phase 1
• Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath TumorCompletedNCT04465643Phase 1
• Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)Active, not recruitingNCT04447651
• Trial to Promote Recovery From COVID-19 With Endocrine TherapyWithdrawnNCT04374279Phase 2
• Bariatric Arterial Embolization for Men Starting Hormones for Prostate CancerWithdrawnNCT04331717Phase 2
• EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionCompletedNCT04266431Not applicable
• Biopsy Collection for Men Undergoing Brachytherapy for Prostate CancerWithdrawnNCT04243473
• Resiliency in Older Adults Undergoing Bone Marrow TransplantCompletedNCT04188678
• Observation of Perioperative Outcomes of Robotic PancreaticoduodenectomyCompletedNCT04171440Not applicable
• Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerActive, not recruitingNCT04117087Phase 1
• SBRT as a Vaccination for Metastatic MelanomaWithdrawnNCT04042506Phase 2
• Therapy for High-Risk HPV 16-Positive Oropharynx Cancer PatientsWithdrawnNCT04001413Phase 2
• Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
• AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing SurgeryTerminatedNCT03965494Early Phase 1
• Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBMCompletedNCT03961971Phase 1
• Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural MesotheliomaActive, not recruitingNCT03918252Phase 2
• A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsCompletedNCT03914794Phase 2
• Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral NeuropathyCompletedNCT03909464
• Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid TumorsActive, not recruitingNCT03875287Phase 1
• Selective Transvenous Chemoembolization of Primary Pancreatic TumorsWithdrawnNCT03865563Phase 1
• Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing GliomaTerminatedNCT03843814Not applicable
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerWithdrawnNCT03800784Phase 2/3
• Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate CancerCompletedNCT03793543Phase 1
• Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)CompletedNCT03792516Phase 1
• Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract CancerWithdrawnNCT03768531Phase 2
• Perspectives on Bone Marrow Donors Who Donate for Their ParentCompletedNCT03758911
• Post-Operative Outcomes of Low Thermal Dissection vs. Traditional ElectrosurgeryCompletedNCT03711916Not applicable
• Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of GlioblastomaTerminatedNCT03707457Phase 1
• A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas CancerWithdrawnNCT03707444
• Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyTerminatedNCT03619655Phase 1
• REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric CancerActive, not recruitingNCT03610711Phase 1/2
• Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 InhibitorActive, not recruitingNCT03607890Phase 2
• A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent GliomasTerminatedNCT03593993
• Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast CancerActive, not recruitingNCT03573648Phase 2
• Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PETCompletedNCT03542773Phase 1
• Cancer, Obesity/Overweight and Insomnia StudyCompletedNCT03542604Not applicable
• Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast CancerWithdrawnNCT03523299Not applicable
• Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.CompletedNCT03497377Phase 1
• Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive FunctionCompletedNCT03487601Not applicable
• Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate CancerActive, not recruitingNCT03471650Phase 2
• A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor MalignanciesTerminatedNCT03471286Phase 1
• Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBCActive, not recruitingNCT03439735Phase 2
• Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer PatientsWithdrawnNCT03372148Not applicable
• Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT03299946Phase 1
• 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma MultiformeCompletedNCT03291990Early Phase 1
• Assessing the Acceptability of the Use of a Mobile Health App Among Young Adult Female Survivors of Childhood CancerCompletedNCT03242200Not applicable
• Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain MetastasesActive, not recruitingNCT03223922Not applicable
• A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission MaintenanceActive, not recruitingNCT03114865Phase 1/2
• Trial of Mistletoe Extract in Patients With Advanced Solid TumorsCompletedNCT03051477Phase 1
• Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerActive, not recruitingNCT03044613Phase 1
• Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, ClarithromycinTerminatedNCT03043989Phase 1
• Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic ChordomaActive, not recruitingNCT02989636Phase 1
• Personalized Molecular Profiling in Cancer Treatment at Johns HopkinsActive, not recruitingNCT02965755Not applicable
• Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate CancerCompletedNCT02856100
• Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT02845323Phase 2
• Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerCompletedNCT02825875
• Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic SyndromeTerminatedNCT02749708Phase 1
• Monitoring Plasma Tumor DNA in Early-Stage Breast CancerCompletedNCT02743910
• Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase InhibitorActive, not recruitingNCT02738866Phase 2
• SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineCompletedNCT02716948Phase 1
• Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
• Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade GliomasTerminatedNCT02659800Phase 1
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)CompletedNCT02658981Phase 1
• Cancer DNA Detection in Blood and UrineCompletedNCT02657863
• Head and Neck Cancer Treatment Related DysphagiaWithdrawnNCT02657850
• Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1

← Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins overview and focus areas